Diabetes Remission: The Good, The Bad and The Ugly
Endocrinology India
0:00 / 0:00
Diabetes Remission: The Good, The Bad and The Ugly
1 626 просмотров · 1 год назад
Endocrinology India
11,6 тыс. подписчиков
1 626 просмотров · 1 год назад
Diabetes Remission: The Good, The Bad and The Ugly by Dr. Om J Lakhani
Diabetes Remission: Truth vs Hype
1. Terminology and Definitions [0:00-5:00]
Correct term is "diabetes remission" not "reversal" or "cure"
Remission implies need for ongoing support and monitoring
Reversal incorrectly suggests no further support needed
Cure is inappropriate as diabetes can return
Analogy to states of matter and cancer remission
Like water changing states, diabetes status can change
Similar to cancer remission requiring ongoing monitoring
2. Official Definition (ADA 2021 Consensus) [5:00-10:00]
Three key criteria:
HbA1c less than 6.5%
Maintenance for at least 3 months
No glucose-lowering medications
Important note: Even medications like SGLT2 inhibitors prescribed for heart failure disqualify remission status
3. Types of Diabetes and Remission Potential [10:00-15:00]
Can Undergo Natural Remission:
Drug-induced diabetes
Gestational diabetes
Hospital/stress hyperglycemia
Can Achieve Remission with Intervention:
Type 2 diabetes (early stages)
Endocrine disorder-related diabetes
After treating underlying condition
Some pancreatic diabetes (early forms)
Cannot Currently Achieve Remission:
Type 1 diabetes (except temporary honeymoon phase)
Most pancreatic diabetes
Most monogenic diabetes (MODY)
4. Pathophysiology of Remission [15:00-25:00]
Balance Theory:
Diabetes results from imbalance between:
Insulin resistance
Insulin production
Remission requires restoring this balance
Twin Cycle Hypothesis (Roy Taylor):
Focuses on two key organs:
Liver: Ectopic fat causes central insulin resistance
Pancreas: Fat deposits reduce beta cell function
Weight loss reduces fat in both organs
5. Strategies for Achieving Remission [25:00-35:00]
Primary Strategy: Weight Loss
Target: 10-15% body weight loss
Methods:
Lifestyle measures
Meal replacement (DIRECT trial)
GLP-1 agonists and other medications
Bariatric surgery
Alternative Strategy:
Early intensive insulin therapy
Particularly successful in Asian populations
Can lead to remission in 44-51% of cases
6. Key Studies [35:00-45:00]
DIRECT Trial:
46% achieved remission at 12 months
36% maintained at 24 months
86% success rate with more than 15kg weight loss
NHS DiRECT Program:
37% achieved remission at 12 months
32% of program completers maintained remission
Bariatric Surgery (SOS Study):
76% medication-free at 2 years
69% maintained at 5 years
7. The Good, Bad, and Ugly [45:00-End]
Good:
Motivating for patients
Reduces cost burden
Focuses on core pathophysiology
Bad:
Can distract from main goal of preventing complications
May lead to inappropriate discontinuation of beneficial medications
Ugly:
Misleading marketing and false promises
Expensive, unproven programs
Misrepresentation of remission criteria
Key Takeaways:
1. Remission ≠ Reversal or Cure
2. Weight loss is primary proven strategy
3. Early intervention has better outcomes
4. Ongoing monitoring remains essential
5. Focus should remain on preventing complications
More Details:
1. Notes (for Doctors): https://www.endocrinology.co.in/notes...
2. Notes (for Patients):https://www.endocrinology.co.in/patie...
3. Mini-App & Tool: • Diabetes Remission: The Good, The Bad and ...
4. Presentation: https://endocrinologyindia.myinstamoj... (Paid)